Siftome Phase 2P

Ranked GEO Datasets

Active GEO index contains 20696 ranked datasets; organism mixed: Homo sapiens (12696), Mus musculus (8000); assay type mixed: bulk RNA-seq (11054), microarray (8279), other assay type (1363). Rankings use the Patient tissue tumor-vs-normal intent with transparent suitability, metadata quality, and warning rules.

Gene snapshot Projects Saved searches CSV Markdown
50 shown of 152 matching datasets Scoring intent-aware-scoring-v15 Batch b69568dd1e4fe1b9ee2d880bf5495d748a7e4c5c11e4107f02528c3be0e76012 Intent Patient tissue tumor-vs-normal Organism Homo sapiens Assay bulk RNA-seq Intent defaults Active 5 active filters Page 3 of 4 · showing 101-150
Active intent defaults Tumor-normal onlyTissue or biopsy onlyHide biofluid/model systemsHuman onlyBulk RNA-seq only
Study designs tumor vs matched normal or tumor vs unmatched normal
Recommendation Recommended means a human bulk RNA-seq tissue or biopsy cohort with clear tumor-normal grouping and sufficient metadata for first-pass triage.
Search intent
Intent defaults Relax defaults

Showing one page of matching results. Use next/previous for browsing, or CSV/Markdown export for the full matching set.

101
GSE154211

RNA-Seq analysis of HCV-related HCC and NBNC-HCC tumor and non-tumor part gene analysis

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 10 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized.
Feedback · 0 stored
102
GSE164441

A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma [RNA-seq]

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 20 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized.
Feedback · 0 stored
103
GSE175492

Transcriptome analysis of normal control and miR-412-3p overexpressing in 786-0 cells

Not suitable Overall 34% Suitability 0% Metadata 85%
Case colorectal cancer Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 6 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Tissue or cell type could not be normalized.
Feedback · 0 stored
104
GSE191334

Bulk RNA-Seq of cutaneous squamous cell carcinomas (cSCC) with paired normal controls

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 16 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized.
Feedback · 0 stored
105
GSE192912

Cancer-associated Fibroblast-derived SPP1 is a Potential Target for Overcoming Sorafenib and Lenvatinib Resistance in Hepatocellular Carcinoma

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 19 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized.
Feedback · 0 stored
106
GSE208089

Comprehensive profile and contrastive analysis of circular RNA in cervical squamous carcinoma and adenocarcinoma

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 3 warnings require review.
GEO Homo sapiens bulk RNA-seq 6 samples intent-aware-scoring-v15
GEO source Trusted counts
info Treated samples may need review depending on the comparison. warning Secondary RNA assay context such as small RNA, miRNA, circRNA, or non-coding RNA was detected. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
107
GSE214846

A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltration

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 130 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized.
Feedback · 0 stored
108
GSE223804

Changes in gene expression and mechanisms underlying activation of tumor invasion and spread at the early steps of squamous cervical carcinoma progression.

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 16 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Tissue or cell type could not be normalized.
Feedback · 0 stored
109
GSE229705

Tumor-adjacent lung transcriptome as a predictor of recurrence in early-stage lung adenocarcinoma [bulk RNA-seq]

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 246 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized.
Feedback · 0 stored
110
GSE241466

Transcriptomic profiling of the intermediate cell carcinoma of the primary liver cancer

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 25 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized.
Feedback · 0 stored
111
GSE24283

Deep transcriptional sequencing analysis of human prostate adenocarcinoma and reference samples

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 8 samples intent-aware-scoring-v15
GEO source Trusted counts
critical Animal sample markers were detected in a human dataset. warning Disease or condition label could not be normalized.
Feedback · 0 stored
112
GSE251942

Hight througput RNA sequencing in a cohort of HBV related HCC and healty liver samples

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 25 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized.
Feedback · 0 stored
113
GSE272510

Lysine metabolism reprogramming reshapes the immune microenvironment and induces immunotherapy tolerance in liver cancer

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 6 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized.
Feedback · 0 stored
114
GSE304512

Developing precision medicine for remote liver cancer patients

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 38 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized.
Feedback · 0 stored
115
GSE33294

Transcriptome sequencing of human hepatocellular carcinoma

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 6 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized.
Feedback · 0 stored
116
GSE58375

SMO variants explain the majority of drug resistance in basal cell carcinoma [RNA-Seq]

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 21 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized.
Feedback · 0 stored
117
GSE77314

RNA-seq of 50 paired hepatocellular carcinoma

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 100 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized.
Feedback · 0 stored
118
GSE81550

RNA-Seq expression profiling of hepatocellular carcinoma and adjacent non-tumor liver tissues

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 1 warning require review.
GEO Homo sapiens bulk RNA-seq 6 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized.
Feedback · 0 stored
119
GSE97214

Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma

Not suitable Overall 34% Suitability 0% Metadata 85%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 18 samples intent-aware-scoring-v15
GEO source Trusted counts
critical Animal sample markers were detected in a human dataset. warning Disease or condition label could not be normalized.
Feedback · 0 stored
120
GSE111423

circRNA profile in hypopharyngeal cancer

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 3 warnings require review.
GEO Homo sapiens bulk RNA-seq 6 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Secondary RNA assay context such as small RNA, miRNA, circRNA, or non-coding RNA was detected. warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
121
GSE112083

RNA-Seq of fibrosarcoma with ESCC case

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 3 warnings require review.
GEO Homo sapiens bulk RNA-seq 2 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Total sample count is below the minimum needed for two comparison groups. warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
122
GSE124535

Gene expression profiles of 35 paired HCC and non-tumor tissues by RNA-seq data

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 70 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
123
GSE126209

Gene expression profiling in Osteosarcomas

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 23 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
124
GSE130078

A Novel LincRNA HERES Epigenetically Regulates Wnt Signaling Pathway via Interaction with EZH2 in Esophageal Squamous Cell Carcinoma

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 3 warnings require review.
GEO Homo sapiens bulk RNA-seq 46 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Secondary RNA assay context such as small RNA, miRNA, circRNA, or non-coding RNA was detected. warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
125
GSE141438

RNA-seq dataset for MPNST patient tissue samples

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 17 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
126
GSE145372

Whole transcriptome sequencing in human cervical adenocarcinoma and normal cervical tissues

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 3 warnings require review.
GEO Homo sapiens bulk RNA-seq 16 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Secondary RNA assay context such as small RNA, miRNA, circRNA, or non-coding RNA was detected. warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
127
GSE146719

Transcriptome analysis in hepatocellular carcinoma (HCC) tissues

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 3 warnings require review.
GEO Homo sapiens bulk RNA-seq 12 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Secondary RNA assay context such as small RNA, miRNA, circRNA, or non-coding RNA was detected. warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
128
GSE148389

MiR-1253 exerts tumor-suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7-H3) (RNA-seq dataset)

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 3 warnings require review.
GEO Homo sapiens bulk RNA-seq 160 samples intent-aware-scoring-v15
GEO source Trusted counts
info Ambiguous sample metadata was detected in 4 sample(s): GSM4467002 matched "unknown"; GSM4467003 matched "unknown"; GSM4467004 matched "unknown"; additional ambiguous samples omitted. Review these samples before inclusion or manual group assignment. warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
129
GSE155800

Identification of transcriptional difference between Imatinib-sensitive and resistant patients with gastrointerstinal stromal tumor (GIST)

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 20 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
130
GSE157373

Integrative analysis of differential circular RNA and long noncoding RNA profiles and associated competing endogenous RNA networks in esophageal squamous cell carcinoma

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 3 warnings require review.
GEO Homo sapiens bulk RNA-seq 6 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Secondary RNA assay context such as small RNA, miRNA, circRNA, or non-coding RNA was detected. warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
131
GSE159330

Expression profiling by small RNA-seq for identifying miRNAs associated with pathological classifications in thyroid cancer.

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 3 warnings require review.
GEO Homo sapiens bulk RNA-seq 34 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Secondary RNA assay context such as small RNA, miRNA, circRNA, or non-coding RNA was detected. warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
132
GSE159721

Genomic and transcriptomic alterations associated with drug vulnerabilities and prognosis in adenocarcinoma at the gastroesophageal junction

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 246 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
133
GSE165595

Genome-wide perturbations of Alu expression and Alu-associated post-transcriptional regulations find a uniqueness in oligodendroglioma

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 82 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
134
GSE166773

Next generation sequencing facilities quantitative analysis of human oropharyngeal squamous cell carcinoma, small cell carcinoma and non-cancerous tonsil tissue.

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 3 warnings require review.
GEO Homo sapiens bulk RNA-seq 3 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Total sample count is below the minimum needed for two comparison groups. warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
135
GSE167573

Next generation sequencing of TFE3-translocation renal cell carcinoma and adjacent normal tissue transcriptomes

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 77 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
136
GSE184616

RNA-seq of HPV-negative Oral Squamous Cell Carcinoma Patients

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 30 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
137
GSE190079

Noncoding RNA expression profiles in five pairs of bladder cancer tumor tissues and matched adjacent non-tumor tissues

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 3 warnings require review.
GEO Homo sapiens bulk RNA-seq 10 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Secondary RNA assay context such as small RNA, miRNA, circRNA, or non-coding RNA was detected. warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
138
GSE194116

Prognostic value of SPODD1 in esophageal squamous cell carcinoma: a comprehensive study based on bioinformatics and validation

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 12 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
139
GSE20116

RNA-Seq of oral squamous cell carcinomas and matched normal tissues

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 6 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
140
GSE205512

Genome-wide methylation analysis of cerebrospinal fluid circulating tumor DNA: a new biomarker for recurrent glioblastoma [mRNA-Seq]

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 3 warnings require review.
GEO Homo sapiens bulk RNA-seq 5 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Dataset has fewer than six samples and should not be treated as a high-confidence cohort without manual review. warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
141
GSE213565

Transcriptional Characterization of Early Esophageal Squamous Cell Carcinoma

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 20 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
142
GSE216115

Biological function and mechanism of circRNA in the occurrence and development of hepatocellular carcinoma

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 4 warnings require review.
GEO Homo sapiens bulk RNA-seq 2 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Total sample count is below the minimum needed for two comparison groups. warning Secondary RNA assay context such as small RNA, miRNA, circRNA, or non-coding RNA was detected. warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
143
GSE216664

Gene expression profiling analysis of laryngeal cancer

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 20 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
144
GSE222421

Circ_0021350 plays an oncogene role by regulating miR-1207-3p/ PIK3R3 in glioblastoma

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 3 warnings require review.
GEO Homo sapiens bulk RNA-seq 8 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Secondary RNA assay context such as small RNA, miRNA, circRNA, or non-coding RNA was detected. warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
145
GSE228393

Gene expression in cancerous and paraneoplastic tissues of patients with head and neck squamous cell carcinoma.

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 3 warnings require review.
GEO Homo sapiens bulk RNA-seq 8 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Secondary RNA assay context such as small RNA, miRNA, circRNA, or non-coding RNA was detected. warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
146
GSE236932

Whole Transcriptome Sequencing Identifies a Competitive Endogenous RNA Network that Regulates the Immunity of Bladder Cancer [RNA-seq]

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 63 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
147
GSE252600

Apolipoprotein L1 is a tumor suppressor in clear cell renal cell carcinoma metastasis [RNA-Seq]

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 18 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
148
GSE273036

Multi-Omics Analysis and Molecular Subtypes Provide Potential Therapeutic Implications in Fumarate Hydratase-deficient Renal Cell Carcinoma

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 93 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
149
GSE299125

Paracrine Signals from HIV-1 Infected Immune Cells Reprogram Cervical Cancer Pathways

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs unmatched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs unmatched normal · Tissue · suitability 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: colorectal/GI relevance is unclear.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 35 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored
150
GSE304579

Alternative End-Joining Activation by miR-21-5p Confers Radiation Resistance in Oral Squamous Cell Carcinoma [RNA-seq of SUGH-OSCC patient tumors]

Not suitable Overall 34% Suitability 0% Metadata 70%
Case tumor sample Control normal tissue
Tumor vs matched normal Tissue
Intent rationale for Patient tissue tumor-vs-normal

Dataset does not meet the current suitability threshold.

  • Tumor vs matched normal · Tissue · suitability 0%.
  • Prioritized for patient tissue tumor-vs-normal triage.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Downgraded disease context: not a colorectal/GI cancer cohort.
  • Processed data is available for downstream review.
  • 2 warnings require review.
GEO Homo sapiens bulk RNA-seq 34 samples intent-aware-scoring-v15
GEO source Trusted counts
warning Disease or condition label could not be normalized. warning Tissue or cell type could not be normalized.
Feedback · 0 stored